Raaj Medisafe India Ltd.

Raaj Medisafe India Ltd.

BBSE:RAAJMEDI
104.02
INR
+0.52
(+0.50%)
1.60EPS
44.64P/E
1.18BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
0.01
3.44
7.8
7.98
9.49
43.25
28.63
32.47
35.49
39.66
47.36
48.72
63.34
Basic EPS, GAAP
-0.94
-2.35
-2.14
-1.65
-2.86
-3.15
-0.57
2.07
2.82
3.06
3.05
4.65
1.1
1.6
Free Cash Flow per Basic Share
-1.94
-0.36
0.28
-0.45
-0.12
-3.36
-2.47
-1.49
1.16
-1.43
-6.75
-11.23
-18.16
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-2.96
-5.86
-7.99
-9.68
-12.53
-15.68
-2.36
0.98
3.79
6.85
9.91
20.37
28.34
- -
Tangible Book Value per Share
-2.96
-5.86
-7.99
-9.68
-12.53
-15.68
-2.36
0.98
3.79
6.85
9.91
20.37
28.34
- -
Basic Weighted Avg Shares
5
5
5
5
5
5
5
11
11
11
11
13
16
15
Sales/Revenue/Turnover
- -
- -
17
39
40
48
218
318
347
386
432
624
800
936
Operating Margin (%)
- -
-20,324.9
-31.44
-8.95
-19.34
-23.21
3.82
10.64
12.58
12.61
13.37
11.33
12.15
11.68
Depreciation Expense
2
2
2
3
3
3
3
7
7
8
8
14
20
23
Net Income, GAAP
-5
-12
-11
-8
-14
-16
-3
23
30
33
33
61
18
24
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
1,815.96
12.19
19.17
11.72
22.39
- -
71.37
68.44
Profit Margin (%)
- -
-28,118.2
-62.19
-21.11
-35.83
-33.19
-1.33
7.23
8.68
8.62
7.7
9.82
2.26
2.53
Working Capital
9
7
-3
-10
-18
-16
-4
8
5
39
26
20
151
- -
LT Debt
41
70
73
79
80
98
79
85
54
66
139
144
370
- -
Total Equity
-15
-30
-40
-49
-63
-79
-12
11
41
75
108
269
467
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-193.36
23.32
22.14
20.57
14.74
- -
3.17
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-270.08
23.64
22.63
21.18
14.89
- -
3.3
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
115.41
57.21
36.32
32.48
4.91
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
277
- -
LT Borrowings
- -
365
- -
LT Finance Leases
- -
5
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
16
16
Market Capitalization
921
1,168
1,176

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
505
- -
Cash, Cash Equivalents & STI
- -
130
- -
Accounts Receivable, Net
- -
118
- -
Inventories
- -
149
- -
Total Current Liabilities
- -
353
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
277
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.48%
126.86%
73.66%
Free Cash Flow
268.37%
35.39%
101.62%
Net Income, GAAP
-86.22%
11.04%
-70.48%
Sales/Revenue/Turnover
65.39%
20.98%
28.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
109
125
146
244
624
2026
158
184
207
251
800
2027
295
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.74
0.49
0.76
2.61
4.65
2026
1.11
1.32
1.44
-1.96
1.1
2027
1.2
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Arpit Bangur
Full Time Employees
101
Sector
Health technology
Industry
Medical specialties
Address
75 Ujjian MP India 456010
IPO Date
Feb 21, 1994
Business
Raaj Medisafe India Limited, incorporated in 1985 and headquartered in Dhar, Madhya Pradesh, specializes in manufacturing plastic packaging and disposable hygiene products. Its core offerings include high-density polyethylene (HDPE) bottles; polypropylene (PP) caps and closures; plastic liners; aluminum crown caps; child-resistant packaging for pharmaceuticals; and eco-friendly food-grade poly bags and sheets. The company also manufactures comprehensive hygiene products such as baby diapers, sanitary pads, maternity pads, and panty liners. It operates primarily through two segments, Plastic and Hygiene, serving clients in India and international markets from its state-of-the-art facility in Pithampur, Madhya Pradesh. Recently, Raaj Medisafe has enhanced its manufacturing capabilities with a focus on sustainability, producing DMF-certified and recyclable packaging materials aligned with global environmental standards. The company appointed Mrs. Fatima Dadani as Chief Financial Officer in August 2025 and engaged new auditing firms, including GDK & Associates as statutory auditors and M. Maheshwari & Associates as secretarial auditors, reflecting governance strengthening. Raaj Medisafe continues to expand product innovation and quality certifications, maintaining ISO 9001:2015, WHO-GMP, and USFDA certifications to support its pharmaceutical and food packaging businesses. Raaj Medisafe India Limited is part of the Packaging People Group and serves diverse industries including pharmaceuticals, food and beverages, and personal hygiene. Its subsidiary, Padma Polytex, operates a cGMP-compliant facility producing specialized poly bags for pharmaceutical applications. The company's strategic focus remains on leveraging technological advancement and sustainability in packaging solutions while expanding its footprint in domestic and overseas markets. Financially, Raaj Medisafe reported strong growth with a 44.32% increase in sales and an 84.08% rise in net profit for the fiscal year ended March 2025, underscoring its operational resilience and market demand.